title: Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation.
abstract: Although mesenchymal stromal cells (MSCs) have been applied clinically to treat cardiac diseases, it is unclear how and to which extent transplanted MSCs exert their beneficial effects. To address these questions, pre-clinical MSC administrations are needed for which pigs appear to be the species of choice. This requires the use of porcine cells to prevent immune rejection. However, it is currently unknown to what extent porcine MSCs (pMSCs) resemble human MSCs (hMSCs). Aim of this study was to compare MSC from porcine bone marrow (BM) with human cells for phenotype, multi-lineage differentiation potential, immune-modulatory capacity and the effect on cardiac function after transplantation in a mouse model of myocardial infarction. Flow cytometric analysis revealed that pMSC expressed surface antigens also found on hMSC, including CD90, MSCA-1 (TNAP/W8B2 antigen), CD44, CD29 and SLA class I. Clonogenic outgrowth was significantly enriched following selection of CD271+ cells from BM of human and pig (129 ± 29 and 1961 ± 485 fold, respectively). hMSC and pMSC differentiated comparably into the adipogenic, osteogenic or chondrogenic lineages, although pMSC formed fat much faster than hMSC. Immuno-modulation, an important feature of hMSC, was clearly demonstrated for pMSC when co-cultured with porcine peripheral blood cells stimulated with PMA and pIL-2. Finally, pMSC transplantation after myocardial infarction attenuated adverse remodelling to a similar extent as hMSC when compared to control saline injection. These findings demonstrate that pMSCs have comparable characteristics and functionality with hMSCs, making reliable extrapolation of pre-clinical pMSC studies into a clinical setting very well possible.
authors.affiliation: Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: W A
authors.initials: WA
authors.lastname: Noort
authors.forename: M I F J
authors.initials: MI
authors.lastname: Oerlemans
authors.forename: H
authors.initials: H
authors.lastname: Rozemuller
authors.forename: D
authors.initials: D
authors.lastname: Feyen
authors.forename: S
authors.initials: S
authors.lastname: Jaksani
authors.forename: D
authors.initials: D
authors.lastname: Stecher
authors.forename: B
authors.initials: B
authors.lastname: Naaijkens
authors.forename: A C
authors.initials: AC
authors.lastname: Martens
authors.forename: H J
authors.initials: HJ
authors.lastname: Bühring
authors.forename: P A
authors.initials: PA
authors.lastname: Doevendans
authors.forename: J P G
authors.initials: JP
authors.lastname: Sluijter
mesh_terms: D017667:Adipocytes / Q000166:cytology / Q000378:metabolism; D050156:Adipogenesis; D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D001854:Bone Marrow Cells / Q000166:cytology; D002454:Cell Differentiation; D049109:Cell Proliferation; D002469:Cell Separation; D020219:Chondrogenesis; D005434:Flow Cytometry; D006334:Heart Function Tests; D006801:Humans; D056747:Immunomodulation / Q000276:immunology*; D016130:Immunophenotyping; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D051379:Mice; D016513:Mice, SCID; D009206:Myocardium / Q000473:pathology*; D010006:Osteoblasts / Q000166:cytology / Q000378:metabolism; D010012:Osteogenesis; D010641:Phenotype; D034421:Sus scrofa; D013601:T-Lymphocytes / Q000166:cytology / Q000378:metabolism
chemical_list: D015703:Antigens, CD